August 2018


July 2018


June 2018

Applications will be reviewed on a rolling basis.Those received by July 30, 2018 will be reviewed and considered on an accelerated basis.


May 2018

2018 GREAT LAKES TRANSLATIONAL GLYCOMICS SYMPOSIUM Registration IS HERE!

Check out the website for more details! 
http://bit.ly/GreatLakesGlycomics


Speakers Announced! 2018 Great Lakes Translational Glycomics Symposium 

Keynote Lecture: Glycomimetic Drugs that Target the Tumor Microenvironment in Clinical Trials for Hematological Malignancies
John Magnani, PhD, GlycoMimetics, Inc. 

Red Blood Cell Glycomics: Past, Present, and Future
Waseem Anani, MD, Associate Medical Director of Transfusion Medicine and Assistant Clinical Professor of Pathology 

Aberrant Sialylation and the Pathobiology of Thrombocytopenia
Melissa Lee-Sundlov, PhD, Blood Research Institute, BloodCenter of Wisconsin 

Glycans in the Bone Marrow Niche
Silvia Giannini, PhD, Brigham and Women’s Hospital 

Platelets Regulate a Novel Mode of Extracellular Glycosylation
Joseph T.Y. Lau, PhD, Roswell Park Comprehensive Cancer Center 

Absence of β-1,4-Galactosyltransferase Severely Affects the Bone Marrow Niche
Leonardo Rivadeneyra, PhD, Blood Research Institute, BloodCenter of Wisconsin 

Integrin Function and Glycans
Jieqing Zhu, PhD, Blood Research Institute 

Development of an Assay to Determine von Willebrand Factor Glycan Composition
Connie Kwas, MS, Blood Research Institute, BloodCenter of Wisconsin 

Poster Presentation
Alicia Eustes, University of Utah

Treatment Strategies for Globoid Cell Leukodystrophy: Successes and Challenges
Mark Sands, PhD, Washington University School of Medicine in St. Louis 

Glycan Changes in Dorsal Root Ganglia are Associated with Fabry Disease Pain
Jimmy Miller, PhD, Medical College of Wisconsin

T Rapa Cells as Delivery Vehicles for α-galactosidase A in Fabry Patients
Murtaza Nagree, Medical College of Wisconsin 

Linking Glycans and Reduced Von Willebrand Factor Survival
Sandra Haberichter, PhD, Blood Research Institute, BloodCenter of Wiscosin 

ATB200: A Novel rhGAA ERT with Optimized Glycosylation for Improved Therapeutic Efficacy
Russell Gotschall, Amicus Therapeutics 

M6PR-specific Targeting of Lysosomal Enzymes Regulates Platelet Production and Function in Mice
Hervé Falet, PhD, Blood Research Institute, BloodCenter of Wisconsin

Glycosaminoglycan Specificity – A Pipe Dream?
Umesh Desai, PhD, Virginia Commonwealth University 

Glycosaminoglycan Modulation of Chemokine Function
Brian Volkman, PhD, Medical College of Wisconsin 

Mapping the Cardiomyocyte Surfaceome: New Technologies for Studying Glycoproteins in Differentiation and Disease
Rebekah Gundry, PhD, Medical College of Wisconsin